Industry & Hardware
Palamedrix
United Stateswww.genomeweb.com/proteomics-protein-research/somalogic-acquire-dna-nanotech-firm-palamedrix-525m
acquired
acquired
Stage
1
Investors
About
Palamedrix develops DNA nanotechnology-based biosensors that enable the measurement of proteins and other analytes with single-molecule sensitivity, supporting proteomics and molecular diagnostics applications.
Explore Palamedrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.